Tracer library / [18F]OP-801
[18F]OP-801
Also written as [18F]OP-801; [F-18]OP-801
- Radionuclide
- F-18 t½ 109.77 min
- Modality
- PET
- Production route
- —
- Stage
- Clinical research
- Syntheses indexed
- 1
What it is
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| TRACERlab FX FN GE HealthCare | custom manifold | HPLC+SPE | 6.89% decay-corrected | 99% | PAMAM-G4-OH alkyne10 dendrimer precursor…PAMAM-G4-OH alkyne10 dendrimer precursor and 3-azidopropyl-4-methylbenzenesulfonate Snapdragon Chemistry | 37310119 2023 ACS Chem Neurosci All chemistry was performed on a TRACERlab FX–FN synthesis module (GE) with an adjacent custom synthesis platform (built in-house) and a remote control HPLC column selector (Cheminert 6 port, VICI) - average of 6.89% (SD 2.23) decay corrected radiochemical yield |
Precursor
- Common precursor
- —
- Suppliers seen in the literature
- —
- Cited suppliers in indexed syntheses
- Snapdragon Chemistry
- Typical final purification
- —
Need this precursor?We can point you to suppliers for [18F]OP-801, or handle the enquiry for you.
Get in touchQuality control Preliminary - inferred from compound class
- Ph. Eur. monograph
- not verified No Ph. Eur. check is recorded for this entry.
- USP monograph
- not verified No USP check is recorded for this entry.
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [18F]OP-801.
Get in touchNotes
Added from reverse module search (stage 6); 1 article(s) with F-18. Compound class inferred from precursor name (not stated outright) -- PMID 37310119: 'polyamidoamine generation 4 hydroxyl alkyne (10) dendrimer (PAMAM-G4-OH alkyne10)'. Stage set/updated at stage 23 from PMID 37310119: 'a phase 1/2 clinical trial (NCT05395624) for first-in-human imaging in healthy controls and patients with amyotrophic lateral sclerosis is underway'. | Stage 28: added indication(s) neu-als from consolidated missing-rubric review. | Stage 30 (2026-09-18): Stage was 'phase 1/2 clinical trial (first-in-human)'; normalised to 'Clinical research', original wording kept here.